$103 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 335 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DOCU | Exit | DOCUSIGN INC | $0 | – | -3,500 | -100.0% | 0.00% | – |
DBD | Exit | DIEBOLD NIXDORF INC | $0 | – | -190,000 | -100.0% | 0.00% | – |
SEER | Exit | SEER INC | $0 | – | -20,200 | -100.0% | 0.00% | – |
MBII | Exit | MARRONE BIO INNOVATIONS INC | $0 | – | -1,458,400 | -100.0% | -0.00% | – |
MTSI | Exit | MACOM TECH SOLUTIONS HLDGS I | $0 | – | -98,300 | -100.0% | -0.00% | – |
TTWO | Exit | TAKE-TWO INTERACTIVE SOFTWAR | $0 | – | -75,000 | -100.0% | -0.01% | – |
SREV | Exit | SERVICESOURCE INTL INC | $0 | – | -6,968,710 | -100.0% | -0.01% | – |
GSK | Exit | GSK PLCsponsored adr | $0 | – | -551,400 | -100.0% | -0.02% | – |
EPZM | Exit | EPIZYME INC | $0 | – | -16,642,727 | -100.0% | -0.02% | – |
TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -542,100 | -100.0% | -0.04% | – |
POLY | Exit | PLANTRONICS INC NEW | $0 | – | -5,403,250 | -100.0% | -0.19% | – |
J | Exit | JACOBS ENGR GROUP INC | $0 | – | -6,350,917 | -100.0% | -0.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
BIOGEN INC. | 42 | Q3 2023 | 6.8% |
AMGEN INC. | 42 | Q3 2023 | 5.3% |
MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
FEDEX CORP | 42 | Q3 2023 | 3.3% |
SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
NN INC | November 09, 2022 | 1,763,640 | 4.0% |
AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.